Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 8Cognitive Dysfunction 4Radiation Injuries 3Multiple Myeloma 2Lymphoma 2Glioma 2Triple Negative Breast Neoplasms 1Stroke 1Parkinson Disease 1Neoplasms 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Localized, Operable Non-small Cell Lung Cancer 1Liver Neoplasms 1Liver Diseases 1Infratentorial Neoplasms 1Glioblastoma 1Fibrosis 1Fatigue 1Epilepsy 1Colorectal Neoplasms 1Cancer Related Cognitive Difficulties 1Breast Neoplasms 1Brain Injuries, Traumatic 1Astrocytoma 1

Interventions

Blood Specimen Collection 5Drug Therapy 3Specimen Handling 2Immune Checkpoint Inhibitors 2Carboplatin 2Biopsy, Large-Core Needle 2Biopsy 2toripalimab 1tislelizumab 1taxane 1sacituzumab govitecan 1pembrolizumab 1atezolizumab 1Zoledronic Acid 1Urine Specimen Collection 1Prophylactic Mastectomy 1Paracentesis 1Neuropsychological Tests 1Mifepristone 1Medicine, Chinese Traditional 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Doxorubicin 1DNA 1Cyclophosphamide 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Triple Negative Breast Neoplasms × Neuropsychological Tests × Clear all
NCT04835597 2024-08-26

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

M.D. Anderson Cancer Center

Terminated
27 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡